News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Palantir flagged as a tactical long after a steep pullback, citing defense contract wins and AI-driven investor rotation.
  • Fundamentals show strong free cash flow and ROE while technicals indicate oversold momentum.
  • White House urged major tech firms to build dedicated power plants to supply data centers and shield consumers from rising power bills.
  • Implementation, enforcement, and firm participation remain unspecified, with a formal White House meeting set for early March.
  • Hong Kong forecasts 2.5%-3.5% growth and expects its fiscal deficit to narrow, improving near-term fiscal outlook.
  • Authorities will accelerate tech and AI development and deepen ties with mainland economic planning to attract investment.

Latest Articles

Indian rupee strengthens to multi‑week high after US-India trade agreement

Indian rupee strengthens to multi‑week high after US-India trade agreement

The Indian rupee jumped in early Tuesday trading following an announcement of a bilateral trade agreement between New Delhi and Washington that reduces U.S. tariffs on Indian goods. The currency fell sharply against the dollar - reaching 90.128 per dollar, its strongest level since mid-January - as markets reacted to the tariff cut, while questions…

Aeluma Ten-Percent Holder Disposes $1.53M in Shares Ahead of Earnings

Aeluma Ten-Percent Holder Disposes $1.53M in Shares Ahead of Earnings

Mark N. Tompkins, a reported 10% owner of Aeluma, Inc. (ALMU), sold a total of $1.53 million in common stock across several trades executed between January 29 and February 2, 2026. The transactions covered a range of prices from $15.74 to $17.16. After the disposals, Tompkins retains direct ownership of 1,824,988 Aeluma shares. ALMU is trading at $…

Ionis Executive Sells $516K in Stock as Company Advances Multiple Programs

Ionis Executive Sells $516K in Stock as Company Advances Multiple Programs

Patrick R. O’Neil, Executive Vice President, CLO and General Counsel of Ionis Pharmaceuticals, sold 6,179 shares on January 30, 2026, for about $516,153 and recorded the vesting of 11,991 performance-based restricted stock units the prior day. The transactions leave O’Neil with 71,983 shares. Separately, Ionis disclosed recent regulatory and clinic…

Ionis EVP Swayze Sells $512K in Stock as Company Advances Pipeline

Ionis EVP Swayze Sells $512K in Stock as Company Advances Pipeline

Eric Swayze, executive vice president of research at Ionis Pharmaceuticals, sold 6,179 shares on January 30, 2026, for about $512,446. The transaction occurred as Ionis shares trade near a 52-week high and follow a separate vesting-related acquisition of 11,991 shares on January 29. The moves come alongside regulatory approvals, positive clinical d…

Ionis CEO Sells $5.2M in Shares Amid Vesting and Strong Stock Rally

Ionis CEO Sells $5.2M in Shares Amid Vesting and Strong Stock Rally

Ionis Pharmaceuticals CEO Brett P. Monia sold roughly $5.2 million worth of company shares on January 30, 2026, after receiving a larger grant the prior day from vested performance-based restricted stock units. The stock is trading near its 52-week high, supported by recent regulatory approvals and positive Phase 3 trial results, while company fina…

Ionis Executive Disposes $515K in Shares After Recent RSU Vesting

Ionis Executive Disposes $515K in Shares After Recent RSU Vesting

Eugene Schneider, executive vice president and chief clinical development officer at Ionis Pharmaceuticals (IONS), sold 6,179 shares on January 30, 2026, for $515,629, after receiving 11,991 performance-based restricted stock units that vested a day earlier. The sale occurred at prices close to the stock’s 52-week high, while the company has seen s…

PubMatic CEO Disposes of 65,592 Shares, Realizing $477,250; Company Posts Q3 Beat and Management Additions

PubMatic CEO Disposes of 65,592 Shares, Realizing $477,250; Company Posts Q3 Beat and Management Additions

PubMatic CEO Rajeev K. Goel sold a combined 65,592 shares of Class A Common Stock in late January and early February 2026 for roughly $477,250. The trades included transactions executed through The Goel Family Trust under a Rule 10b5-1 plan. Separately, Goel exercised options and converted Class B shares into Class A shares. PubMatic also reported …

Charles R. Schwab Sells $15 Million in SCHW Stock as Company Announces Dividend Hike and Bank Leadership Shift

Charles R. Schwab Sells $15 Million in SCHW Stock as Company Announces Dividend Hike and Bank Leadership Shift

Charles R. Schwab, Co-Chairman of Charles Schwab Corporation (NYSE: SCHW), sold 145,650 shares on January 29, 2026, for roughly $15 million at a weighted average price of $103.1649. The transaction leaves him with substantial direct and indirect holdings. The firm also announced a 19% dividend increase and an internal leadership change at Charles S…

SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology

SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology

SoftBank Corp's unit Saimemory and Intel Corporation have agreed to collaborate on commercializing a new memory architecture called Z-Angle operation memory technology. The partners said the work targets memory chips that combine high capacity, high bandwidth and reduced power consumption, intended for use in artificial intelligence data centers. T…

Solid Biosciences CFO Sells Shares to Cover Taxes After PSU Vesting

Solid Biosciences CFO Sells Shares to Cover Taxes After PSU Vesting

Solid Biosciences Inc. Chief Financial Officer Kevin Tan sold 26,837 shares of common stock on February 2, 2026, in a set of transactions that generated about $172,747. The disposition, reported on a Form 4, was executed to meet withholding tax obligations tied to the recent vesting of performance stock units. The company continues to report clinic…